Related Experiment Video
Updated: Jan 20, 2026

MRI and PET in Mouse Models of Myocardial Infarction
Published on: December 19, 2013
Beyond Parkinsonism: 18 F-FDOPA Brain PET/MRI for Detection of High-grade Glioma
Michelle Chen1, Martin Niethammer2, Ana M Franceschi1
1Department of Radiology, Neuroradiology Division, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.
Abstract:
A 72-year-old man presented with right-sided rigidity and bradykinesia, but the history and neurological examination were not entirely compatible with degenerative parkinsonism. Initial MRI showed T2/FLAIR hyperintensity within the splenium, attributed to small vessel disease. Subsequent 18 F-FDOPA brain PET/MRI ruled out degenerative parkinsonism, but revealed avid tracer uptake (SUVmax 4.46) in the splenium corresponding to signal abnormality on structural imaging. This unexpected finding prompted contrast-enhanced MRI brain, which identified a peripherally enhancing splenium lesion concerning for neoplasm. Stereotactic biopsy confirmed GFAP-positive, diffuse high-grade glioblastoma, IDH-wildtype, WHO Grade 4, highlighting the role of FDOPA PET in the assessment of primary brain tumors.
Insights
A patient with parkinsonism symptoms was diagnosed with glioblastoma using 18F-FDOPA PET/MRI. This imaging technique revealed an unexpected tumor in the brain
Area of Science:
- Neuroimaging
- Neurology
- Oncology
Background:
- A 72-year-old male presented with parkinsonian symptoms, but clinical presentation was atypical for degenerative parkinsonism.
- Initial MRI revealed splenium T2/FLAIR hyperintensity, initially presumed to be small vessel disease.
Purpose of the Study:
- To investigate the cause of atypical parkinsonism and splenium abnormalities.
- To evaluate the utility of 18F-FDOPA PET/MRI in differentiating parkinsonism and assessing brain lesions.
Main Methods:
- Performed 18F-FDOPA brain PET/MRI to assess for degenerative parkinsonism.
- Utilized contrast-enhanced MRI to further characterize the splenium lesion.
- Conducted stereotactic biopsy for histopathological confirmation.
Main Results:
- 18F-FDOPA PET/MRI excluded degenerative parkinsonism and showed high tracer uptake in the splenium (SUVmax 4.46).
- Contrast-enhanced MRI identified a peripherally enhancing splenium lesion suggestive of neoplasm.
- Biopsy confirmed diffuse high-grade glioblastoma, IDH-wildtype, WHO Grade 4.
Conclusions:
- 18F-FDOPA PET/MRI can be crucial in diagnosing primary brain tumors presenting with atypical neurological symptoms.
- This case highlights the value of 18F-FDOPA PET in identifying and characterizing brain neoplasms.
Related Concept Videos
10:46MRI and PET in Mouse Models of Myocardial Infarction
10:48PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
04:27Co-culturing Glutamatergic Neurons and Pediatric High-Grade Glioma Cells
06:27A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
10:35Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia
10:02Whole-body PET/MRI of Pediatric Patients: The Details That Matter

